Additionally, treatment using this plasmin nanoformulation showed an improved stroke outcome in a photothrombotic stroke model, indicating that it could be used as an efficient and safe thrombolytic agent compared to free plasmin treatment, without causing significant hemorrhagic risk. Here, PLG is linked to stroke disorder.